|
Gene Banucci has led ATMI, Inc. (Nasdaq: ATMI) as Chairman and CEO since co-founding the Company in 1986. He, along with the founding team of scientists, had a vision of creating a preeminent semiconductor materials company. The company went public in 1993 with only $7 million in revenues, and grew to $300 million in 2000 due to an aggressive technology development and M&A strategy.
As a result of the technology downturn of 2001-2002, Gene initiated a major strategic realignment of the Company that led to the divestment of over one-third of the Company’s product lines while simultaneously growing the Company’s core business over 40%. At the end of 2004, Gene decided to make strategy, investor relations and governance his primary activities and moved to an executive Chairman role with the Company.
Prior to starting ATMI, Gene served as Vice President for American Cyanamid’s Chemical Research Division, where he directed more than 600 scientists and engineers in new product research and development for this $1.4 billion unit. Previously, he was with General Electric Company for over 10 years in a variety of management positions at the Corporate R&D Center and GE Plastics.
Gene’s excellent communication skills, especially his unique ability to build solid, long-lasting relationships with semiconductor industry executives, have been a prime reason for the long term growth of ATMI. Gene has broad experience in investor relations, strategy development, and corporate governance best practices. Most importantly, his personal integrity leads to a high degree of credibility and trust among customers, shareholders and employees.
Gene is a founding member of the Connecticut Technology Council, a member of the Board of the Program on Innovation and Technology of the National Research Council, a member of the Board of Directors of Zygo, Inc. (Nasdaq:ZIGO), Emosyn International, and a member of the Board of Trustees of Beloit College. He received his PhD in Organic Chemistry from Wayne State University, and his BA in Chemistry from Beloit College. Gene holds 21 issued U.S. patents and is the author of numerous published articles. | 